Sulodexide Withdrawn Phase 4 Trials for Diabetic Nephropathy Type 2 Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03504566Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)